Everest Organics

319.00
-7.05
(-2.16%)
Market Cap
309.70 Cr
EPS
0.17
PE Ratio
59.93
Dividend Yield
0.00 %
Industry
Healthcare
52 Week High
330.00
52 Week Low
112.50
PB Ratio
4.66
Debt to Equity
1.18
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
1,787.40
#1 4,28,857.10
36.35
#1 49,887.20
12.06
#1 9,648
13.77
59.27
6,012.50
1,59,613.00
77.18
8,184.00
0.89
1,600
#1 64.53
57.99
1,525.90
1,23,234.00
24.69
26,520.70
14.17
4,155
47.38
57.43
3,238.90
1,09,619.10
58.81
10,785.70
11.59
1,656
13.54
52.37
2,557.50
1,05,517.00
51.57
10,615.60
19.57
1,942
-16.38
59.98
1,174.80
98,031.80
#1 18.23
28,905.40
12.36
5,578
1.69
54.12
2,019.60
92,203.00
32.12
20,141.50
#1 19.94
1,936
38.82
50.28
859.65
86,500.90
19.07
19,831.50
13.82
3,831
29.92
46.44
1,220.10
70,863.60
20.06
29,559.20
17.55
3,169
-10.04
58.85
29,705.00
63,121.10
47.37
6,097.20
10.80
1,201
16.01
45.94
Growth Rate
Revenue Growth
4.26 %
Net Income Growth
-150.00 %
Cash Flow Change
-10.86 %
ROE
-176.92 %
ROCE
72.40 %
EBITDA Margin (Avg.)
44.69 %

Yearly Financial Results

Annual Financials
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
TTM
Revenue
107
100
108
113
156
169
183
202
190
198
172
Expenses
98
94
101
105
138
148
159
194
182
186
164
EBITDA
8
6
7
8
18
21
24
9
8
12
8
Operating Profit %
7 %
6 %
6 %
6 %
11 %
12 %
13 %
3 %
1 %
6 %
3 %
Depreciation
3
3
2
3
3
3
3
4
5
6
6
Interest
3
3
3
3
3
3
3
3
3
6
5
Profit Before Tax
2
0
2
2
12
14
17
2
0
1
-4
Tax
0
0
0
1
5
3
4
1
0
1
0
Net Profit
2
0
1
2
8
11
14
1
-0
0
-4
EPS in ₹
1.78
0.54
1.69
2.14
9.39
13.62
17.14
1.43
-0.23
0.17
-5.20

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
67
76
86
94
107
120
135
178
202
227
Fixed Assets
24
27
33
34
39
39
44
49
55
52
Current Assets
42
47
49
58
67
79
89
118
133
150
Capital Work in Progress
0
1
1
1
0
1
0
8
12
21
Investments
0
0
0
0
0
0
0
0
0
0
Other Assets
43
47
52
60
69
80
92
121
136
153
Total Liabilities
67
76
86
94
107
120
135
178
202
227
Current Liabilities
50
56
63
67
71
74
77
113
138
160
Non Current Liabilities
11
14
7
8
10
12
11
19
18
21
Total Equity
6
6
16
19
26
34
47
47
46
46
Reserve & Surplus
-4
3
8
11
18
26
39
39
38
38
Share Capital
9
3
8
8
8
8
8
8
8
8

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
0
0
0
-0
1
0
-0
-1
0
0
Investing Activities
-3
-7
-8
-4
-5
-6
-12
-17
-16
-13
Operating Activities
4
7
10
5
9
10
14
14
18
16
Financing Activities
-2
-0
-2
-1
-3
-3
-2
2
-3
-3

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Jan 2025
Mar 2025
Promoter
74.15 %
74.15 %
74.15 %
74.15 %
74.15 %
74.15 %
74.15 %
74.15 %
74.15 %
74.15 %
74.15 %
74.15 %
74.15 %
74.15 %
74.15 %
74.15 %
61.09 %
61.09 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
DIIs
0.03 %
0.03 %
0.03 %
0.03 %
0.03 %
0.03 %
0.03 %
0.03 %
0.03 %
0.03 %
0.03 %
0.03 %
0.06 %
0.06 %
0.05 %
0.05 %
0.02 %
0.02 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
19.04 %
18.48 %
18.27 %
18.84 %
18.91 %
19.27 %
19.29 %
19.38 %
19.40 %
19.41 %
19.60 %
19.99 %
20.00 %
20.05 %
20.13 %
18.63 %
32.22 %
23.87 %
Others
6.78 %
7.34 %
7.56 %
6.99 %
6.91 %
6.55 %
6.53 %
6.44 %
6.42 %
6.41 %
6.22 %
5.83 %
5.79 %
5.75 %
5.67 %
7.17 %
6.67 %
15.02 %
No of Share Holders
8,122
11,174
10,784
11,135
11,154
11,244
11,250
11,100
10,834
10,634
10,494
10,242
10,023
9,792
9,996
9,326
8,795
8,756

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 0.00 0.00 1 1 1.5 0.00 0.00 0.00 0.00
Dividend Yield (%) 0.00 0.00 0.00 1.05 0.43 0.86 0.00 0.00 0.00 0.00

Corporate Action

Announcements

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 09, 2025
Announcement under Regulation 30 (LODR)-Change in Corporate Office AddressApr 04, 2025
Announcement under Regulation 30 (LODR)-Change in Corporate Office AddressApr 04, 2025
Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance OfficerMar 27, 2025
Closure of Trading WindowMar 24, 2025
Receipt Of Trading Approval From BSE LimitedMar 20, 2025
Receipt Of Listing Approval From BSE LimitedMar 12, 2025
Intimation Of Korea Drug Master File (KDMF) Approval For CompanyS Rabeprazole Sodium APIFeb 18, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 13, 2025
Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportFeb 13, 2025
Shareholder Meeting / Postal Ballot-Outcome of Postal_BallotFeb 13, 2025
Integrated Filing (Financial)Feb 11, 2025
Board Meeting Outcome for Outcome Of The Board Meeting Held TodayFeb 11, 2025
Un-Audited Financial Results For The Quarter And Nine Months Ended December 31 2024.Feb 11, 2025
Board Meeting Intimation for Board Meeting Scheduled To Be Held On Tuesday February 11 2025.Feb 05, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 22, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Jan 15, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Jan 15, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Jan 15, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationJan 14, 2025
Certificate From Statutory Auditor In Terms Of Regulation 169(4) & (5) Of The SEBI (ICDR) Regulations 2018Jan 13, 2025
Shareholder Meeting / Postal Ballot-Notice of Postal BallotJan 13, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementJan 13, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementJan 13, 2025
Announcement under Regulation 30 (LODR)-AllotmentJan 13, 2025
Board Meeting Outcome for Outcome Of Board Meeting Dated 13.01.2025Jan 13, 2025
Board Meeting Intimation for AllotmentJan 08, 2025
Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportJan 08, 2025
Shareholder Meeting / Postal Ballot-Outcome of EGMJan 08, 2025
Closure of Trading WindowDec 27, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationDec 18, 2024
Notice Of EGM Scheduled To Be Held On Wednesday, January 08, 2025Dec 17, 2024
Additional Information Required Under SEBI Circular No. SEBI/HO/CFD/CFD-Pod-1/P/CIR/2023/123 Dated July 13, 2023 Read With Regulation 30 Of SEBI(LODR) Regulations, 2015 In Continuation To The Outcome Of Board Meeting Submitted On December 12, 2024Dec 16, 2024
Announcement under Regulation 30 (LODR)-Preferential IssueDec 13, 2024
Corrigendum To The Outcome Of Board Meeting Held On December 12, 2024Dec 13, 2024
Board Meeting Outcome for 1. Increase Of Authorised Share Capital2. Issue Of Equity Shares On Preferential BasisDec 12, 2024
Board Meeting Intimation for For Fund Raising Through Preferential IssueDec 09, 2024
Cancellation of Board MeetingDec 09, 2024
Board Meeting Intimation for Prior Intimation Of Board Meeting Going To Be Held On 10Th December, 2024 To Consider Preferential Issue.Dec 07, 2024
Announcement under Regulation 30 (LODR)-Resignation of DirectorDec 07, 2024
Announcement under Regulation 30 (LODR)-Resignation of DirectorDec 04, 2024
Announcement under Regulation 30 (LODR)-Resignation of DirectorDec 04, 2024
Announcement under Regulation 30 (LODR)-Resignation of DirectorDec 04, 2024
Newspaper Publication Of Quarterly Financial ResultNov 14, 2024
Appointment Of Company SecretaryNov 13, 2024
Appointment Of DirectorNov 13, 2024
Board Meeting Outcome for Outcomes Of The MeetingNov 13, 2024
Financial Result For Quarter Ended 30-09-2024Nov 13, 2024
Board Meeting Intimation for Considering And Approving The Un-Audited Financial Results Of The Company For The Quarter Ended September 30, 2024Nov 08, 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Oct 15, 2024

Technical Indicators

RSI(14)
Neutral
69.25
ATR(14)
Volatile
17.48
STOCH(9,6)
Overbought
84.02
STOCH RSI(14)
Neutral
57.83
MACD(12,26)
Bullish
1.85
ADX(14)
Weak Trend
12.07
UO(9)
Bearish
64.26
ROC(12)
Uptrend And Accelerating
15.90
WillR(14)
Overbought
-13.43